Aaron M. Tsumura

Hematology
2279 45th St
Sacramento, CA 95817

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications

Cellular therapy in older adults with relapsed/refractory diffuse large B-cell lymphoma.

Cellular therapy in older adults with relapsed/refractory diffuse large B-cell lymphoma.

Journal: Frontiers in oncology
Published: August 16, 2024

Checkpoint inhibition in hematologic malignancies.

Checkpoint inhibition in hematologic malignancies.

Journal: Frontiers in oncology
Published: September 03, 2023

BCR-ABL+ Chronic Myeloid Leukemia Arising in a Family With Inherited ANKRD26-Related Thrombocytopenia.

BCR-ABL+ Chronic Myeloid Leukemia Arising in a Family With Inherited ANKRD26-Related Thrombocytopenia.

Journal: JCO precision oncology
Published: October 10, 2020

Acyl protein thioesterase 1 and 2 (APT-1, APT-2) inhibitors palmostatin B, ML348 and ML349 have different effects on NRAS mutant melanoma cells.

Acyl protein thioesterase 1 and 2 (APT-1, APT-2) inhibitors palmostatin B, ML348 and ML349 have different effects on NRAS mutant melanoma cells.

Journal: Oncotarget
Published: August 30, 2015

Metformin and trametinib have synergistic effects on cell viability and tumor growth in NRAS mutant cancer.

Metformin and trametinib have synergistic effects on cell viability and tumor growth in NRAS mutant cancer.

Journal: Oncotarget
Published: October 08, 2014

Mutant NRASQ61 shares signaling similarities across various cancer types--potential implications for future therapies.

Mutant NRASQ61 shares signaling similarities across various cancer types--potential implications for future therapies.

Journal: Oncotarget
Published: October 04, 2014
Showing 1-6 of 6

Last Updated: 09/26/2026